ArticleClinics (Sao Paulo, Brazil)2023

Trastuzumab-induced human cardiomyocyte damage through the Notch2/JAK2/STAT3 pathway.

Zhenbo Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.